Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Crit Rev Food Sci Nutr ; 63(19): 3943-3958, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-34748444

RESUMEN

Probiotics consumption has been associated with various health promoting benefits, including disease prevention and even treatment by modulating gut microbiota. Contrary to this, probiotics may also overstimulate the immune system, trigger systemic infections, harmful metabolic activities, and promote gene transfer. In children, the fragile immune system and impaired intestinal barrier may boost the occurrence of adverse effects following probiotics' consumption. To overcome these health challenges, the key focus has been shifted toward non-viable probiotics, also called paraprobiotics. Cell wall polysaccharides, peptidoglycans, surface proteins and teichoic acid present on cell's surface are involved in the interaction of paraprobiotics with the host, ultimately providing health benefits. Among other benefits, paraprobiotics possess the ability to regulate innate and adaptive immunity, exert anti-adhesion, anti-biofilm, anti-hypertensive, anti-inflammatory, antioxidant, anti-proliferative, and antagonistic effects against pathogens, while also enhance clinical impact and general safety when administered in children in comparison to probiotics. Clinical evidence have underlined the paraprobiotics impact in children and young infants against atopic dermatitis, respiratory and gastrointestinal infections, in addition to be useful for immunocompromised individuals. Therefore, this review focuses on probiotics-related issues in children's health and also discusses the Lactobacillus and Bifidobacterium spp. qualities for qualifying as paraprobiotics and their role in promoting the children's health.


Asunto(s)
Salud Infantil , Probióticos , Lactante , Niño , Humanos , Suplementos Dietéticos , Probióticos/uso terapéutico , Intestinos/microbiología , Lactobacillus/fisiología
2.
Medicina (Kaunas) ; 56(9)2020 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-32867260

RESUMEN

The positive impact of probiotic strains on human health has become more evident than ever before. Often delivered through food, dietary products, supplements, and drugs, different legislations for safety and efficacy issues have been prepared. Furthermore, regulatory agencies have addressed various approaches toward these products, whether they authorize claims mentioning a disease's diagnosis, prevention, or treatment. Due to the diversity of bacteria and yeast strains, strict approaches have been designed to assess for side effects and post-market surveillance. One of the most essential delivery systems of probiotics is within food, due to the great beneficial health effects of this system compared to pharmaceutical products and also due to the increasing importance of food and nutrition. Modern lifestyle or various diseases lead to an imbalance of the intestinal flora. Nonetheless, as the amount of probiotic use needs accurate calculations, different factors should also be taken into consideration. One of the novelties of this review is the presentation of the beneficial effects of the administration of probiotics as a potential adjuvant therapy in COVID-19. Thus, this paper provides an integrative overview of different aspects of probiotics, from human health care applications to safety, quality, and control.


Asunto(s)
Infecciones por Coronavirus/prevención & control , Suplementos Dietéticos/normas , Enfermedades Gastrointestinales/terapia , Hepatopatías/terapia , Pandemias/prevención & control , Neumonía Viral/prevención & control , Probióticos/uso terapéutico , Betacoronavirus , COVID-19 , Enfermedad Celíaca/terapia , Infecciones por Clostridium/terapia , Estreñimiento/terapia , Infecciones por Coronavirus/tratamiento farmacológico , Infecciones por Coronavirus/terapia , Trastorno Depresivo/terapia , Enfermedades Diverticulares/terapia , Disentería/terapia , Enterocolitis Necrotizante/terapia , Alimentos Fermentados , Hipersensibilidad a los Alimentos/terapia , Infecciones por Helicobacter/terapia , Encefalopatía Hepática/terapia , Humanos , Enfermedades Inflamatorias del Intestino/terapia , Enfermedad del Hígado Graso no Alcohólico/terapia , Neumonía Viral/terapia , Probióticos/efectos adversos , Probióticos/normas , Control de Calidad , SARS-CoV-2 , Tratamiento Farmacológico de COVID-19
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA